tiprankstipranks
Advertisement
Advertisement

MX:NVON Stock Latest News

Scholar Rock removes Catalent Indiana from apitegromab BLA under FDA guidance
The FlyScholar Rock removes Catalent Indiana from apitegromab BLA under FDA guidance
1d ago
NVO
SRRK
Moderately bullish activity in Novo Nordisk with shares up 1.32%
PremiumThe Fly
Moderately bullish activity in Novo Nordisk with shares up 1.32%
3d ago
NVO
Novo Nordisk testing lower doses of oral Wegovy, Reuters reports
PremiumThe Fly
Novo Nordisk testing lower doses of oral Wegovy, Reuters reports
3d ago
LLY
NVO
Novo Nordisk Expands Treasury Stock as 2026 Share Buyback Passes DKK 8 Billion
PremiumCompany Announcements
Novo Nordisk Expands Treasury Stock as 2026 Share Buyback Passes DKK 8 Billion
5d ago
6K
NVO
Novo Nordisk downgraded to Hold from Buy at Berenberg
PremiumThe Fly
Novo Nordisk downgraded to Hold from Buy at Berenberg
6d ago
NVO
Novo Nordisk Expands Treasury Position as 2026 Share Buyback Nears DKK 8 Billion
PremiumCompany AnnouncementsNovo Nordisk Expands Treasury Position as 2026 Share Buyback Nears DKK 8 Billion
12d ago
6K
NVO
Novo Nordisk reports vesting of 100th Anniversary restricted shares to board and EVP
Premium
Company Announcements
Novo Nordisk reports vesting of 100th Anniversary restricted shares to board and EVP
12d ago
6K
NVO
Scholar Rock to remove Catalent Indiana facility from apitegromab BLA
Premium
The Fly
Scholar Rock to remove Catalent Indiana facility from apitegromab BLA
15d ago
NVO
SRRK
Novo Nordisk price target lowered to DKK 310 from DKK 330 at Citi
PremiumThe Fly
Novo Nordisk price target lowered to DKK 310 from DKK 330 at Citi
16d ago
NVO
Novo Nordisk price target raised to $47 from $45 at BMO Capital
PremiumThe Fly
Novo Nordisk price target raised to $47 from $45 at BMO Capital
16d ago
NVO
Cboe data shows mixed options sentiment in Novo Nordisk with shares up 0.6%
PremiumThe Fly
Cboe data shows mixed options sentiment in Novo Nordisk with shares up 0.6%
17d ago
NVO
Novo Nordisk Lifts 2026 Guidance as Wegovy Pill Drives Q2 Obesity Growth
PremiumCompany Announcements
Novo Nordisk Lifts 2026 Guidance as Wegovy Pill Drives Q2 Obesity Growth
18d ago
6K
NVO
Novo Nordisk Lifts 2026 Outlook After Strong Q2 Adjusted Results
PremiumCompany AnnouncementsNovo Nordisk Lifts 2026 Outlook After Strong Q2 Adjusted Results
18d ago
6K
NVO
Novo Nordisk reports Q2 adjusted sales DKK 78.49B, up 7% at CER
Premium
The Fly
Novo Nordisk reports Q2 adjusted sales DKK 78.49B, up 7% at CER
18d ago
NVO
Novo Nordisk raises FY26 adjusted sales view to 0% to down 6% from down 4%-12%
Premium
The Fly
Novo Nordisk raises FY26 adjusted sales view to 0% to down 6% from down 4%-12%
18d ago
NVO
Novo Nordisk Details Progress in DKK 15 Billion Share Buyback Programme
PremiumCompany Announcements
Novo Nordisk Details Progress in DKK 15 Billion Share Buyback Programme
18d ago
6K
NVO
Midday Fly By: Amazon passes $3T market cap, Astra in tie-up talks with Bristol
PremiumThe Fly
Midday Fly By: Amazon passes $3T market cap, Astra in tie-up talks with Bristol
19d ago
L
TT
Monte Rosa Therapeutics price target lowered to $27 from $37 at Wedbush
PremiumThe Fly
Monte Rosa Therapeutics price target lowered to $27 from $37 at Wedbush
19d ago
NVO
GLUE
Novo Nordisk sees optimism as Wegovy pill leads against Foundayo, Reuters says
PremiumThe Fly
Novo Nordisk sees optimism as Wegovy pill leads against Foundayo, Reuters says
20d ago
NVO
NVO Earnings this Week: How Will it Perform?
PremiumPre-EarningsNVO Earnings this Week: How Will it Perform?
20d ago
NVO
Novo Nordisk: Neutral Rating Maintained as Obesity Franchise Faces GLP‑1 Competition and Shares Trade Near DKK 350 Target
Premium
Ratings
Novo Nordisk: Neutral Rating Maintained as Obesity Franchise Faces GLP‑1 Competition and Shares Trade Near DKK 350 Target
20d ago
NVO
Monte Rosa, BioAge sink following Novo Nordisk’s ZEUS setback
Premium
The Fly
Monte Rosa, BioAge sink following Novo Nordisk’s ZEUS setback
22d ago
NVO
BIOA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >